Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • Pfizer extends cooperation deal with Israeli AI drug development firm CytoReason
10 Feb

Pfizer extends cooperation deal with Israeli AI drug development firm CytoReason

By admin 0 Comments

Tel Aviv-based startup uses machine learning to build computational models of human diseases to speed up treatment discoveries

Details
Vote up!
Vote down!

Points: 2

Category: 
Tech Israel
CytoReason
Pfizer
pharmaceuticals
  • Log in or register to post comments

Author

anon

admin

Hot

  • Israeli Airstrike Hits U.S.-Sanctioned Weapons Facility in Shiraz
  • In Surprise Move, Rav Don Segal Departs for U.S. to Join Emergency Keren Olam HaTorah Mission
  • “IT’S ABOUT TIME”: Trump Celebrates US’ Long History Beating Foreign Enemies at Massive Military Parade (Videos)

User login

  • Create new account
  • Request new password

Recent comments

No comments available.